Relative Bioavailability of NXP001 Compared to Emend® in Healthy Volunteers
NCT03889366
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Aprepitant 125 mg
Sponsor
Nuformix Technologies Limited